Alimera Sciences

1 follower

Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera”), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Our lead product is ILUVIEN, now approved for marketing in the U...






Rick Eiswirth
President, CEO & Interim CFO

Rick Eiswirth

David Holland
CMO & SVP, Corporate Communications & Managed Markets
Philip Ashman
COO & SVP, Commercial Operations Europe
David Dyer
Chief Retina Specialist
Steve Gill
Vice President, Thought Leader Engagement At Alimera Sciences
Christopher Visick
Vice President, General Counsel
Laura Cegala Sphr, Gphr
Vice President, Human Capital
Benjamin Simon
Senior Director, Global Quality Assurance
Adam Morgan
Chairman Of The Board
Rn Bsn Amy Vie
Regional Sales Director
Brittany Underhill
Associate Director, Financial Reporting
Larry Karner
Vice President, Managed Markets
Mike Padilla
Vice President Of Global Marketing/head Of Commercial Excellence
Riz Siddiqi
Medical Director, UK & Eire
Steve Lobb
Vp, Sales Director Europe
Steve Morris
Vice President , Medical Director Uk, Head Of Medical Affairs Europe
Trey Kincaid
Senior Director, Finance & Corporate Controller
Bill Garner
Executive Director Marketing